Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts)

Sandra M. Dold, MSc, BSc, Veronika Riebl, Dagmar Wider, Marie Follo, PhD, Stefan J. Mueller, Ingrid Bartsch, Milena Pantic, PhD, Cornelius Miething, MD, Chrissoula Kiote-Schmidt, K. Martin Kortüm, MD, Mihaela Zlei, Abdel Kareem Azab, PhD, Mascha Binder, MD, Justyna Rawluk, Justus Duyster, Prof., Robert Zeiser, MD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2018) 132 (Supplement 1): 3222.

https://doi.org/10.1182/blood-2018-99-112489

Published: 2018

Journal Articles

Towards Improved Models of NPM-ALK Induced T-Cell Lymphoma

Sophia Ehrenfeld, MSc, Khalid Shoumariyeh, Teresa Poggio, Robin Khan, Desiree Melanie Redhaber, Stefanie Kreutmair, MD, Cathrin Klingeberg, Anna Lena Illert, MD, Justus Duyster, Prof., Cornelius Miething, MD

Blood (2018) 132 (Supplement 1): 1342.

https://doi.org/10.1182/blood-2018-99-115872

Published: 2018

Journal Articles

Functional Characterization of Epigenetic Modifiers of Demethylating Therapy in AML

Desiree Melanie Redhaber, Laurent Phely, Sophia Ehrenfeld, MSc, Pia Veratti, Silvia Schäfer, Jan Mitschke, Jessica Beckert, Khalid Shoumariyeh, Justus Duyster, Prof., Cornelius Miething, MD

Blood (2018) 132 (Supplement 1): 1465.

https://doi.org/10.1182/blood-2018-99-116818

Published: 2018

Journal Articles

Implementation of a Molecular Tumor Board in Clinical Decision Making at the Medical Center University of Freiburg

Blood (2016) 128 (22): 3579.

https://doi.org/10.1182/blood.V128.22.3579.3579

Published: 2016

Journal Articles

Myelodysplastic Syndrome Caused By Activating Kras Mutation in the Non-Hematopoietic Bone Marrow Microenvironment

Lena Osswald, Cornelius Miething, MD, Justus Duyster, MD PhD, Tilman Brummer, PhD, Robert Zeiser, MD

Blood (2015) 126 (23): 359.

https://doi.org/10.1182/blood.V126.23.359.359

Published: 2015

Journal Articles

Tumor Associated Macrophage Expression, CD163, Is Associated with Poorer Outcome in Diffuse Large B-Cell Lymphoma

Olga L. Bohn, MD, Jocelyn C. Maragulia, Hilda Crispin, Camille Gonzalez, Cornelius Miething, MD, Andrew D. Zelenetz, MD, PhD, Julie Teruya-Feldstein, MD

Blood (2012) 120 (21): 1583.

https://doi.org/10.1182/blood.V120.21.1583.1583

Published: 2012

Journal Articles

A Single Retroviral Vector Design for the Simultaneous Expression of a Mir30 Based Shrna with An Oncogene – Identification of Raf-1 but Not BRAF as a Crucial Mediator for BCR-ABL Mediated Leukemogenesis.

Corinna Albers, Anna Lena Illert, MD, Hannes Leischner, Cornelius Miething, MD, Richard Huss, Christian Peschel, MD, Justus Duyster, MD

Blood (2010) 116 (21): 3392.

https://doi.org/10.1182/blood.V116.21.3392.3392

Published: 2010

Journal Articles

Raf1 Is Required for Induction of a Bcr-Abl Positive CML Like Myeloproliferative Disease in Mice

Corinna Albers, Anna Lena Illert, MD, Cornelius Miething, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2008) 112 (11): 3207.

https://doi.org/10.1182/blood.V112.11.3207.3207

Published: 2008

Journal Articles

Grb10 Mediated Akt Activation Is Required for Induction of CML Like Myeloproliferative Disease in Mice by BCR-ABL.

Corinna Albers, Anna L. Illert, MD, Cornelius Miething, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2007) 110 (11): 1012.

https://doi.org/10.1182/blood.V110.11.1012.1012

Published: 2007

Journal Articles

The Oncogenic Fusionprotein NPM-ALK Cooperates with Bcl2 To Induce T-Cell Lymphomas in Mice.

Cornelius Miething, MD, Rebekka Grundler, PhD, Claudia Mugler, Anette Bauer, Georg Häcker, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2006) 108 (11): 2058.

https://doi.org/10.1182/blood.V108.11.2058.2058

Published: 2006

Journal Articles

Interferon Regulatory Factor 4 Is Not Required for Induction of Chronic Myeloid Leukaemia-Like Myeloproliferative Disease by Bcr/Abl in Mice.

Anna Lena Illert, MD, Cornelius Miething, MD, Rebekka Grundler, PhD, Manuel Schmidt, PhD, Andreas Burchert, MD, Andreas Neubauer, MD, Claudia Mugler, Christian Peschel, MD, Justus Duyster, MD

Blood (2005) 106 (11): 2866.

https://doi.org/10.1182/blood.V106.11.2866.2866

Published: 2005

Journal Articles

The Transcription Factors RUNX1/AML1 and RUNX3/AML2 Protect Bcr-Abl-Transformed B-Cells from Imatinib Induced Apoptosis.

Cornelius Miething, MD, Rebekka Grundler, PhD, Claudia Mugler, Heike Pfeifer, MD, Oliver Ottmann, MD, Simone Barwisch, Michael Speicher, PhD, Christian Peschel, MD, Justus Duyster, MD

Blood (2005) 106 (11): 540.

https://doi.org/10.1182/blood.V106.11.540.540

Published: 2005

Journal Articles

Imatinib and Leptomycin B Are Effective in Overcoming Imatinib-Resistance Due to Bcr-Abl Amplification or Clonal Evolution but Not Due to Bcr-Abl Kinase Domain Mutation.

Rama K. Kancha, MSc, Cornelius Miething, MD, Nikolas V. Bubnoff, MD, Katharina Gotze, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2005) 106 (11): 2003.

https://doi.org/10.1182/blood.V106.11.2003.2003

Published: 2005

Journal Articles

A New Method of Retroviral Lineage Specific Expression Utilizing the Cre/lox System Induces a T-Lymphoid Malignancy in a Mouse Model of ALCL.

Cornelius Miething, MD, Rebekka Grundler, Claudia Mugler, Christian Peschel, MD, Justus Duyster, MD

Blood (2004) 104 (11): 348.

https://doi.org/10.1182/blood.V104.11.348.348

Published: 2004

Journal Articles

FLT3 ITD and FLT3 Tyrosine Kinase Domain Mutants Induce Different Phenotypes in a Murine Bone Marrow Transplant Model.

Rebekka Grundler, Cornelius Miething, MD, Christian Thiede, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2004) 104 (11): 3371.

https://doi.org/10.1182/blood.V104.11.3371.3371

Published: 2004

NARROW

Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts)

Towards Improved Models of NPM-ALK Induced T-Cell Lymphoma

Functional Characterization of Epigenetic Modifiers of Demethylating Therapy in AML

Implementation of a Molecular Tumor Board in Clinical Decision Making at the Medical Center University of Freiburg

Myelodysplastic Syndrome Caused By Activating Kras Mutation in the Non-Hematopoietic Bone Marrow Microenvironment

Tumor Associated Macrophage Expression, CD163, Is Associated with Poorer Outcome in Diffuse Large B-Cell Lymphoma

A Single Retroviral Vector Design for the Simultaneous Expression of a Mir30 Based Shrna with An Oncogene – Identification of Raf-1 but Not BRAF as a Crucial Mediator for BCR-ABL Mediated Leukemogenesis.

Raf1 Is Required for Induction of a Bcr-Abl Positive CML Like Myeloproliferative Disease in Mice

Grb10 Mediated Akt Activation Is Required for Induction of CML Like Myeloproliferative Disease in Mice by BCR-ABL.

The Oncogenic Fusionprotein NPM-ALK Cooperates with Bcl2 To Induce T-Cell Lymphomas in Mice.

Interferon Regulatory Factor 4 Is Not Required for Induction of Chronic Myeloid Leukaemia-Like Myeloproliferative Disease by Bcr/Abl in Mice.

The Transcription Factors RUNX1/AML1 and RUNX3/AML2 Protect Bcr-Abl-Transformed B-Cells from Imatinib Induced Apoptosis.

Imatinib and Leptomycin B Are Effective in Overcoming Imatinib-Resistance Due to Bcr-Abl Amplification or Clonal Evolution but Not Due to Bcr-Abl Kinase Domain Mutation.

A New Method of Retroviral Lineage Specific Expression Utilizing the Cre/lox System Induces a T-Lymphoid Malignancy in a Mouse Model of ALCL.

FLT3 ITD and FLT3 Tyrosine Kinase Domain Mutants Induce Different Phenotypes in a Murine Bone Marrow Transplant Model.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only